Our findings indicate that the ACVR1 R206H mutation can allow human iPS cells to form chondrocytes and mineralize in vitro without a clear fibro-proliferative stage as in FOP patients. Here, ACVR1 is linked to fibrodysplasia ossificans progressiva.